ModSys International Ltd. develops and markets enterprise legacy information technology (IT) modernization solutions worldwide. Its technologies and services allow businesses to migrate from their legacy mainframe and distributed IT infrastructures to modern environments and programming languages. The company's activities include the conversion of legacy mainframe applications written in COBOL, CA GEN, Natural, and PL/1 to Java and C# code; conversion of legacy databases, such as IDMS, ADABAS, VSAM, IMS, and ICL to SQL Server, Oracle, and DB2 environments; and selling Replatforming software that allow companies to modernize their databases from ADABAS to Oracle, SQL Server or DB2, and get off the mainframe while keeping their application in legacy natural codebase. It also provides professional services comprising project management of migrations, understanding and mapping of the applications, testing, remediation, and ongoing monitoring and management of the environments. ModSys International Ltd. offers its modernization solutions directly to customers; or through its strategic partners, including system integrators and other software vendors. The company was formerly known as BluePhoenix Solutions Ltd. and changed its name to ModSys International Ltd. in January 2015. ModSys International Ltd. was founded in 1987 and is headquartered in Seattle, Washington.
Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. The company focuses on diseases affecting the back of the eye or retina. The company offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness. Its ILUVIEN is inserted in the back of the patient's eye to a placement site that uses the eye's natural fluid dynamics to deliver the corticosteroid fluocinolone acetonide (FAc). It has license agreements with pSivida US, Inc. for the development and sale of ILUVIEN, and a delivery device to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans (other than uveitis) or to treat DME. Alimera Sciences, Inc. was founded in 2003 and is headquartered in Alpharetta, Georgia.
Support.com, Inc. provides cloud-based software and services in North America. It offers Nexus, a cloud based software-as-a-service solution that provides automation and analytics for companies to resolve technology issues and optimize support interactions with their customers. The company also provides technology support services, including computer and mobile device set-up, security and support, virus and malware removal, wireless network set-up, and home security and automation system support services to the consumer and small business markets. In addition, it offers software products to maintain, optimize, and secure computers and mobile devices, including SUPERAntiSpyware, a software for malware protection and removal; Cosmos for PC, smartphone, and tablet maintenance and optimization; and ARO for PC registry cleaning and repair. The company sells its cloud based services through partners, including communication providers, retailers, and technology companies, as well as markets its end-user software products directly, principally online, and through partners. Support.com, Inc. was founded in 1997 and is headquartered in Redwood City, California.
CIM Commercial Trust Corp is a publicly owned real estate investment trust. The firm invests in the real estate markets of United States. It also engages in lending activities. CIM Commercial Trust Corp was founded in 1993 and is based in Dallas, Texas.
Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. The company is developing SPK-RPE65, which is in Phase III clinical trial for the treatment of inherited retinal dystrophies, a group of rare blinding conditions caused by non-sex linked, or autosomal recessive, mutations in the RPE65 gene. It is also developing SPK-CHM for the treatment of choroideremia; and preclinical programs in development for the treatment of hemophilia A and neurodegenerative diseases, as well as a pipeline of product candidates targeting rare blinding conditions. The company has collaboration agreement with Pfizer, Inc. for the development and commercialization of SPK-FIX product candidates in its gene therapy program for the treatment of hemophilia B. Spark Therapeutics, Inc. was founded in 2013 and is based in Philadelphia, Pennsylvania.
Hawaiian Telcom Holdco, Inc. provides communications services and products to residential and business customers in Hawaii. The company operates through two segments, Telecommunications and Data Center Colocation. The Telecommunications segment provides local telephone services, including voice and data transport, custom calling features, network access, directory assistance, and private lines; and high-speed Internet, long distance, television, Internet protocol-based network, managed, billing and collection, wireless, and pay telephone services, as well as customer premises equipment and data solutions. As of December 31, 2014, this segment served approximately 343,500 local access lines; approximately 181,200 long distance lines; and approximately 113,300 high-speed Internet lines, including approximately 92,900 retail residential lines, 18,300 retail business lines, and 800 wholesale business and resale lines. The Data Center Colocation segment offers data center services, including colocation and virtual private cloud. The company has operations in the islands of Oahu, Maui, Hawaii, Kauai, Molokai, and Lanai. Hawaiian Telcom Holdco, Inc. was founded in 1883 and is headquartered in Honolulu, Hawaii.
YUM! Brands, Inc., together with its subsidiaries, operates quick service restaurants. It operates in five segments: YUM China, YUM India, the KFC Division, the Pizza Hut Division, and the Taco Bell Division. The company develops, operates, franchises, and licenses a system of restaurants, which prepare, package, and sell various food items. As of August 18, 2015, it operated approximately 41,000 restaurants in approximately 125 countries and territories primarily under the KFC, Pizza Hut, and Taco Bell brands, which specialize in chicken, pizza, and Mexican-style food categories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was founded in 1997 and is headquartered in Louisville, Kentucky.
American DG Energy Inc. owns, operates, maintains, and distributes on-site energy systems that produce electricity, hot water, heat, and cooling at customers' facilities in the United States and the United Kingdom. The company owns and installs equipment at customers' facilities, and sells the energy produced by these systems to customers on a long-term contractual basis. It offers natural gas powered cogeneration systems, which produces electricity from an internal combustion engine driving a generator, while the heat from the engine and exhaust is recovered and used to produce heat and hot water for use at the site. The company also distributes and operates water chiller systems for building cooling applications. It offers standardized packages of energy, equipment, and services to the needs of property owners and operators in healthcare, hospitality, residential, athletic facilities, and various industrial sites. As of December 31, 2014, the company operated 123 energy systems representing an aggregate of approximately 8,186 kilowatts of installed electricity plus thermal energy, 60.0 million British thermal units of heat and hot water, and 4,525 tons of cooling. American DG Energy Inc. was incorporated in 2001 and is headquartered in Waltham, Massachusetts.
Civitas Solutions, Inc., through its subsidiaries, provides home- and community-based health and human services to individuals with intellectual, developmental, physical or behavioral disabilities, and other special needs in the United States. It operates in two segments, Human Services and Post-Acute Specialty Rehabilitation Services. The company's human services comprise residential support, day habilitation, vocational services, case management, crisis intervention, and hourly support services for adults and children with intellectual and/or developmental disabilities; and therapeutic foster care, family preservation, adoption services, early intervention, school-based services, and juvenile offender programs for youth with emotional, behavioral, and/or medically complex challenges. It also provides post-acute specialty rehabilitation services, such as neurorehabilitation, neurobehavioral rehabilitation, specialized nursing, supported living, outpatient treatment, and pre-vocational services, as well as physical, occupational, and speech therapies for individuals who have suffered acquired brain injury, spinal injuries, and other catastrophic injuries and illnesses. Civitas Solutions, Inc. serves governmental agencies, non-public payors, and not-for-profit organizations. The company was formerly known as NMH Holdings, Inc. The company was founded in 1980 and is based in Boston, Massachusetts. Civitas Solutions, Inc. is a subsidiary of NMH Investment, LLC.
FS Investment Corporation is a business development company specializing in investments in debt securities. It seeks to purchase interests in loans through secondary market transactions or directly from the target companies as primary market investments. It also seeks to invest in first lien senior secured loans, second lien secured loans and, to a lesser extent, subordinated loans, or mezzanine loans. In connection with the debt investments, the firm also receives equity interests such as warrants or options as additional consideration. It also seek to purchase minority interests in the form of common or preferred equity in our target companies, either in conjunction with one of the debt investments or through a co-investment with a financial sponsor. Additionally, on an opportunistic basis, the fund may also invest in corporate bonds and similar debt securities. The fund does not seek to invest in start-up companies, turnaround situations, or companies with speculative business plans. It seeks to invest in small and middle-market companies based in United States. The fund seeks to invest in firms with annual revenue between $10 million to $2.5 billion. It seeks to exit from securities by selling them in a privately negotiated over- the- counter market. For any investments that are not able to be sold within the secondary market, the firm seeks to exit such investments through repayment, an initial public offering of equity securities, merger, sale or recapitalization.